Fairpointe Capital LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 64 filers reported holding OVID THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Fairpointe Capital LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$288,000
+2.5%
71,700
-41.1%
0.44%
+736.5%
Q4 2020$281,000
-59.8%
121,7000.0%0.05%
-53.6%
Q3 2020$699,000
-25.2%
121,700
-3.9%
0.11%
-17.6%
Q2 2020$934,000
+121.3%
126,700
-10.6%
0.14%
+115.9%
Q1 2020$422,000
-28.2%
141,7000.0%0.06%
+40.0%
Q4 2019$588,000
+79.8%
141,700
+40.3%
0.04%
+164.7%
Q3 2019$327,000
+74.9%
101,0000.0%0.02%
+112.5%
Q2 2019$187,000
+4.5%
101,0000.0%0.01%
+33.3%
Q1 2019$179,000
+80.8%
101,000
+146.3%
0.01%
+100.0%
Q4 2018$99,00041,0000.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders